211
Views
2
CrossRef citations to date
0
Altmetric
Articles

Towards strain-independent anti-influenza peptides: a SAXS- and modeling-based study

, , &
Pages 1720-1733 | Received 06 Jun 2013, Accepted 07 Aug 2013, Published online: 02 Sep 2013

References

  • Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006). The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics, 22, 195–201.
  • Bodian, D. L., Yamasaki, R. B., Buswell, R. L., Stearns, J. F., White, J. M., & Kuntz, I. D. (1993). Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry, 32, 2967–2978.
  • Bohne-Lang, A., & von der Lieth, C. W. (2005). GlyProt: In silico glycosylation of proteins. Nucleic Acids Research, 33, W214–219.
  • Bullough, P. A., Hughson, F. M., Skehel, J. J., & Wiley, D. C. (1994). Structure of influenza haemagglutinin at the pH of membrane fusion. Nature, 371, 37–43.
  • Burch, J., Corbett, M., Stock, C., Nicholson, K., Elliot, A. J., Duffy, S., … Stewart, L. (2009). Prescription of anti-influenza drugs for healthy adults: A systematic review and meta-analysis. Lancet Infectious Diseases, 9, 537–545.
  • Chen, M. W., Cheng, T. J., Huang, Y., Jan, J. T., Ma, S. H., Yu, A. L., … Ho, D. D. (2008). A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proceedings of the National Academy of Sciences United States of America, 105, 13538–13543.
  • Cheng, A. C., Coleman, R. G., Smyth, K. T., Cao, Q., Soulard, P., Caffrey, D. R., … Huang, E. S. (2007). Structure-based maximal affinity model predicts small-molecule druggability. Nature Biotechnology, 25, 71–75.
  • Cheng, P. K., To, A. P., Leung, T. W., Leung, P. C., Lee, C. W., & Lim, W. W. (2010). Oseltamivir- and amantadine-resistant influenza virus A (H1N1). Emerging Infectious Diseases, 16, 155–156.
  • Dennis, S., Kortvelyesi, T., & Vajda, S. (2002). Computational mapping identifies the binding sites of organic solvents on proteins. Proceedings of the National Academy of Sciences U S A, 99, 4290–4295.
  • Epand, R. M., & Epand, R. F. (2002). Thermal denaturation of influenza virus and its relationship to membrane fusion. Biochemical Journal, 365, 841–848.
  • Fields, G. B., & Noble, R. L. (1990). Solid-phase peptide-synthesis utilizing 9-fluorenylmethoxycarbonyl amino-acids. International Journal of Peptide and Protein Research, 35, 161–214.
  • Fleishman, S. J., Whitehead, T. A., Ekiert, D. C., Dreyfus, C., Corn, J. E., Strauch, E. M., … Baker, D. (2011). Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science, 332, 816–821.
  • Fontana, J., Cardone, G., Heymann, J. B., Winkler, D. C., & Steven, A. C. (2012). Structural changes in influenza virus at low pH characterized by cryo-electron tomography. Journal of Virology, 86, 2919–2929.
  • Fuller, J. C., Burgoyne, N. J., & Jackson, R. M. (2009). Predicting druggable binding sites at the protein-protein interface. Drug Discovery Today, 14, 155–161.
  • Goh, G. K., Dunker, A. K., & Uversky, V. N. (2009). Protein intrinsic disorder and influenza virulence: The 1918 H1N1 and H5N1 viruses. Virology Journal, 6, 69–80.
  • Hajduk, P. J., Huth, J. R., & Fesik, S. W. (2005). Druggability indices for protein targets derived from NMR-based screening data. Journal of Medicinal Chemistry, 48, 2518–2525.
  • Harrison, S. C. (2008). Viral membrane fusion. Nature Structural & Molecular Biology, 15, 690–698.
  • Hassantoufighi, A., Zhang, H., Sandbulte, M., Gao, J., Manischewitz, J., King, L., … Eichelberger, M. C. (2010). A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses. Vaccine, 28, 790–797.
  • Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J., & Svergun, D. I. (2003). PRIMUS: A windows PC-based system for small-angle scattering data analysis. Journal of Applied Crystallography, 36, 1277–1282.
  • Koradi, R., Billeter, M., & Wuthrich, K. (1996). MOLMOL: A program for display and analysis of macromolecular structures. Journal of Molecular Graphics, 14, 51–55.
  • Kozakov, D., Hall, D. R., Chuang, G. Y., Cencic, R., Brenke, R., Grove, L. E., … Vajda, S. (2011). Structural conservation of druggable hot spots in protein–protein interfaces. Proceedings of the National Academy of Sciences U S A, 108, 13528–13533.
  • Liu, J., Stevens, D. J., Haire, L. F., Walker, P. A., Coombs, P. J., Russell, R. J., … Skehel, J. J. (2009). Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957. Proceedings of the National Academy of Sciences U S A, 106, 17175–17180.
  • Nayal, M., & Honig, B. (2006). On the nature of cavities on protein surfaces: Application to the identification of drug-binding sites. Proteins, 63, 892–906.
  • Rathore, Y. S., Rehan, M., Pandey, K., Sahni, G., & Ganguly, A. (2011). First structural model of full-length human tissue-plasminogen activator: A SAXS data-based modeling study. The Journal of Physical Chemistry B, 116, 496–502.
  • Ruigrok, R. W., Wrigley, N. G., Calder, L. J., Cusack, S., Wharton, S. A., Brown, E. B., & Skehel, J. J. (1986). Electron microscopy of the low pH structure of influenza virus haemagglutinin. EMBO Journal, 5, 41–49.
  • Russell, R. J., Kerry, P. S., Stevens, D. J., Steinhauer, D. A., Martin, S. R., Gamblin, S. J., & Skehel, J. J. (2008). Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proceedings of the National Academy of Sciences U S A, 105, 17736–17741.
  • Schmidtke, P., & Barril, X. (2010). Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. Journal of Medicinal Chemistry, 53, 5858–5867.
  • Schulze, I. T. (1997). Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. Journal of Infectious Diseases, 176, S24–28.
  • Smith, R. D., Hu, L., Falkner, J. A., Benson, M. L., Nerothin, J. P., & Carlson, H. A. (2006). Exploring protein-ligand recognition with binding MOAD. Journal of Molecular Graphics and Modelling, 24, 414–425.
  • Soundararajan, V., Tharakaraman, K., Raman, R., Raguram, S., Shriver, Z., Sasisekharan, V., & Sasisekharan, R. (2009). Extrapolating from sequence–the 2009 H1N1 ‘swine’ influenza virus. Nature Biotechnology, 27, 510–513.
  • Suhre, K., & Sanejouand, Y. H. (2004). ElNemo: A normal mode web server for protein movement analysis and the generation of templates for molecular replacement. Nucleic Acids Research, 32, 610–614.
  • Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L. M., … Marasco, W. A. (2009). Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nature Structural & Molecular Biology, 16, 265–273.
  • Svergun, D. I. (1992). Determination of the regularization parameter in indirect-transform methods using perceptual criteria. Journal of Applied Crystallography, 25, 495–503.
  • Svergun, D. I. (1999). Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophysical Journal, 76, 2879–2886.
  • Svergun, D., Barberato, C., & Koch, M. H. J. (1995). CRYSOL – A program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates. Journal of Applied Crystallography, 28, 768–773.
  • Sylte, M. J., & Suarez, D. L. (2009). Influenza neuraminidase as a vaccine antigen. Current Topics in Microbiology and Immunology, 333, 227–241.
  • Volkamer, A., Griewel, A., Grombacher, T., & Rarey, M. (2010). Analyzing the topology of active sites: on the prediction of pockets and subpockets. Journal of Chemical Information and Modeling, 50, 2041–2052.
  • Volkov, V. V., & Svergun, D. I. (2003). Uniqueness of ab initio shape determination in small-angle scattering. Journal of Applied Crystallography, 36, 860–864.
  • Wade, R. C. (1997). ‘Flu’ and structure-based drug design. Structure, 5, 1139–1145.
  • Wang, C. C., Chen, J. R., Tseng, Y. C., Hsu, C. H., Hung, Y. F., Chen, S. W., … Wong, C. H. (2009). Glycans on influenza hemagglutinin affect receptor binding and immune response. Proceedings of the National Academy of Sciences U S A, 106, 18137–18142.
  • Wang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., … Palese, P. (2010). Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proceedings of the National Academy of Sciences, 107, 18979–18984.
  • Wharton, S. A., Ruigrok, R. W., Martin, S. R., Skehel, J. J., Bayley, P. M., Weis, W., & Wiley, D. C. (1988). Conformational aspects of the acid-induced fusion mechanism of influenza virus hemagglutinin. Circular dichroism and fluorescence studies. Journal of Biological Chemistry, 263, 4474–4480.
  • Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981). Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature, 289, 366–373.
  • Xu, R., & Wilson, I. A. (2011). Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. Journal of Virology, 85, 5172–5182.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.